Evidence map›Paper›PMID 34070220›Full record

ArticleMolecules (Basel, Switzerland)2021

Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer's Disease.

Ines ELBini-Dhouib, Raoudha Doghri, Amenallah Ellefi, Imen Degrach, Najet Srairi-Abid, Asma Gati

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Targeting Ferroptosis/Nrf2 Pathway Ameliorates AlClInternational journal of molecular sciences · 2025
    Article
  17. Dietary supplements for prevention of Alzheimer's disease:Iranian journal of basic medical sciences · 2025
    Article
  18. Article
  19. Article
  20. Role of CD36 in central nervous system diseases.Neural regeneration research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ines ELBini-DhouibLaboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis, 1002 Tunis, Tunisia.ORCID 0000-0002-2224-0211
Raoudha DoghriLaboratory of Anatomo-Pathology, Institut Salah Azaiez, 1006 Tunis, Tunisia.
Amenallah EllefiLaboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis, 1002 Tunis, Tunisia.
Imen DegrachAnimal Unit, Institut Pasteur de Tunis, 1002 Tunis, Tunisia.
Najet Srairi-AbidLaboratory of Biomolecules, Venoms and Theranostic Applications, LR20IPT01, Institut Pasteur of Tunis, 1002 Tunis, Tunisia.
Asma GatiLaboratory of Genetics, Immunology and Human Pathology, Faculté des Sciences de Tunis, Université Tunis El Manar, 2092 Tunis, Tunisia.
Institut Pasteur de Tunis · TNInstitut Salah-Azaïz · TNTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases leading to dementia. Despite research efforts, currently there are no effective pharmacotherapeutic options for the prevention and treatment of AD. Recently, numerous studies highlighted the beneficial effects of curcumin (CUR), a natural polyphenol, in the neuroprotection. Especially, its dual antioxidant and anti-inflammatory properties attracted the interest of researchers. In fact, besides its antioxidant and anti-inflammatory properties, this biomolecule is not degraded in the intestinal tract. Additionally, CUR is able to cross the blood-brain barrier and could therefore to be used to treat neurodegenerative pathologies associated with oxidative stress, inflammation and apoptosis. The present study aimed to assess the ability of CUR to induce neuronal protective and/or recovery effects on a rat model of neurotoxicity induced by aluminum chloride (AlCl

Indexed as

AcetylcholinesteraseAluminum ChlorideAlzheimer DiseaseAnimalsAnxietyApoptosisBody WeightCell SurvivalCognitive DysfunctionCurcuminCytokinesDisease Models, AnimalHippocampusInflammationInflammation MediatorsMaleAcetylcholinesteraseAluminum ChlorideCurcuminCytokinesInflammation MediatorsNeuroprotective Agentsaluminumanti-inflammatoryantioxidantneuroprotective

Identifiers

PMID34070220
PMCPMC8158738
OpenAlexW3162421839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.